Radiation InjuriesRadiation DosageRadiation, IonizingLeukemiaDose-Response Relationship, RadiationRadiation ToleranceRadiotherapyAntineoplastic AgentsRadiotherapy DosageLeukemia, Myeloid, AcuteRadiationCombined Modality TherapyRadiation ProtectionRadiation OncologyRadiotherapy, ConformalRadiation MonitoringRadiotherapy, Intensity-ModulatedDose FractionationLeukemia, Lymphocytic, Chronic, B-CellRadiotherapy Planning, Computer-AssistedRadiotherapy, AdjuvantRadiation PneumonitisNeoplasmsCell Line, TumorBrachytherapyLeukemia, LymphoidNeoplasms, Radiation-InducedLeukemia, ExperimentalRadiometryTreatment OutcomeRadiation-Sensitizing AgentsRadiation Injuries, ExperimentalDrug Screening Assays, AntitumorGamma RaysRadiosurgeryApoptosisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCosmic RadiationDoxorubicinBrain NeoplasmsCranial IrradiationRadiotherapy, Computer-AssistedCisplatinAntineoplastic Combined Chemotherapy ProtocolsCell SurvivalLeukemia Virus, MurineNeoplasm Recurrence, LocalLeukemia, Radiation-InducedParticle AcceleratorsRadiotherapy, Image-GuidedPrecursor Cell Lymphoblastic Leukemia-LymphomaDrug Resistance, NeoplasmBackground RadiationTime FactorsTumor Cells, CulturedRadiation-Protective AgentsHead and Neck NeoplasmsRadiodermatitisBreast NeoplasmsRadiotherapy, High-EnergyNeoplasm StagingRetrospective StudiesSurvival AnalysisAntineoplastic Agents, PhytogenicUltraviolet RaysDNA DamageDisease-Free SurvivalOrgans at RiskSurvival RateProstatic NeoplasmsRadiation EffectsPrognosisAntibiotics, AntineoplasticCobalt RadioisotopesLeukemia L1210Carcinoma, Squamous CellLeukemia, T-CellFollow-Up StudiesXenograft Model Antitumor AssaysChemoradiotherapyMice, NudeEtoposideLeukemia, Monocytic, AcuteAdenocarcinomaRadiobiologyTomography, X-Ray ComputedFluorouracilTumor BurdenCell ProliferationX-RaysLeukemia P388Lung NeoplasmsMoloney murine leukemia virusDrug Delivery SystemsDose-Response Relationship, DrugVincristineMastectomy, SegmentalChemotherapy, AdjuvantLeukemia, Hairy CellAcute Radiation Syndrome